NCT02432027

Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test

A Single-Center, Randomized, Observer Blind, Vehicle- and Comparator-controlled Trial to Evaluate the Antipsoriatic Efficacy and Safety of Topical Formulations of C-82 in a Psoriasis Plaque Test

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 14 (actual)
• Sponsor: Prism Pharma Co., Ltd. · Industry
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Evaluate the effects of topical C-82 in a psoriasis plaque test.

Detailed description

The primary objective of this trial is to evaluate antipsoriatic efficacy of the C-82 topical gel compared with vehicle by measurement of the thickness of the Echo Lucent Band (ELB) of the psoriatic infiltrate using 20 MHz sonography. To gain additional information about possible efficacy the change of the test fields compared to untreated plaque will be clinically assessed by visual scoring.

Conditions

• Psoriasis

Interventions

Type	Name	Description
DRUG	C-82 Topical Gel, Placebo	placebo
DRUG	C-82 Topical Gel, 1%	active
DRUG	Daivonex cream	comparator
DRUG	Diprosis gel	comparator

Timeline

• Start date: 2015-06-01
• Primary completion: 2015-08-01
• Completion: 2015-09-01
• First posted: 2015-05-01
• Last updated: 2017-08-17

Locations

1 site across 1 country: Germany